Navigation Links
Harnessing genomic research

Regeneration of spinal nerve cells, a new way to personalise breast cancer treatment, rapid near-patient diagnosis of meningitis, MRSA and Chlamydia and effective vaccines to protect against salmonella are all important applications to have benefited from a £30M research programme built around harnessing knowledge of the human and other genomes.

A key feature of this LINK Applied Genomics Programme has been effective collaboration between industry and academia aimed at accelerating the application of knowledge of genomics in biomedicine and healthcare.

The programme funded 21 projects covering diverse research areas. Highlights from the programme include:

Nerve tissue regeneration- During spinal cord injury the nerves that transmit information between the brain and the body are injured and fail to regrow. The loss of this communication leads to paralysis and loss of sensation. Scientists at King's College London and Oxford BioMedica are investigating a receptor which allows nerve cells to reform severed connections. Identifying the genes that contribute to this regeneration will allow the team to understand why damaged nerve cells are unable to repair themselves. The work could lead to ways of stimulating nerves to regrow and repair damaged connections.

Personalised cancer treatment- A large number of cancers are linked to mutations in a specific gene or biological pathway. Researchers from KuDOS pharmaceuticals, Imperial College London and the Gurdon Institute, Cambridge are exploring ways to identify molecular signatures resulting from the loss of specific gene function in breast cancers that will correlate with susceptibility to a new anti-cancer drug being developed by KuDOS. The drug involved has the potential to kill tumour cells without affecting normal cells, so avoiding the side effects of hair-loss and nausea that often result from existing therapies. The genes and biological pathway under investigation are in
'"/>

Source:Biotechnology and Biological Sciences Research Council


Page: 1 2

Related biology news :

1. Harnessing microbes, one by one, to build a better nanoworld
2. Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
3. Enzyme shown to help protect genomic stability
4. New comparative toxicogenomics database
5. Scientists document complex genomic events leading to the birth of new genes
6. Study of genomic DNA leads to new advances in cancer diagnostics
7. Measuring the impact of post-genomics on Mediterranean populations
8. Genrate: a generative model that finds and scores new genes and exons in genomic microarray data
9. PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information
10. Owl genomics presents a HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis
11. Enlisting genomics to understand flu evolution
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Harnessing genomic research

(Date:8/5/2015)... According to a new market research report, ... (BFSI, Airport, IT & Telecom, Utilities, Education, Defense & ... published by MarketsandMarkets, defines and segments the Physical Identity ... global PIAM Market is estimated to grow from $272.2 ... a CAGR of 14.9 % from 2014 to 2019. ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
(Date:8/4/2015)... N.Y., Aug. 4, 2015  AMRI (NASDAQ: AMRI ) today ... 30, 2015. Highlights: , Second quarter contract ... from 2014 , Adjusted contract margins of ... of $0.22, including a $0.05 decrease in EPS from royalties in ... $16 million "We are very pleased to present ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... the degenerative inflammatory bone disease, may be a sign of ... the Annals of the Rheumatic Diseases. , The authors base ... between 30 and 79. Most of them were female twins. ... to check for signs of osteoarthritis and a blood sample ...
... a chemist by training, first ventured into nerve regeneration ... would have considered him crazy. , His idea was ... by neurotransmitters (chemical messengers) to communicate between the brain ... neurotransmitters into the material used to repair a broken ...
... Manchester researchers are recruiting people with backache caused by ... first ever study to discover if therapeutic ultrasound can ... team at the University's Centre for Rehabilitation Science need ... less than 12 weeks, are not pregnant and have ...
Cached Biology News:Osteoarthritis may be sign of faster 'biological ageing' 2Dopamine used to prompt nerve tissue to regrow 2
(Date:8/30/2015)... England , August 31, 2015 ...   einer Frau   für chirurgische   Behandlung     ... von 7-90   werden für eine   verheerende ... 1200 Frauen behandeln und die Anzahl ausgebildeter Chirurgen in ... Astellas gab heute bekannt, dass  Action on Fistula ...
(Date:8/28/2015)... ... August 28, 2015 , ... Pittcon is pleased to announce ... session on chemical spectroscopic imaging at JASIS 2015 (Japan Analytical & Scientific Instruments ... and scientific instruments show which will be held at International Conference Hall in ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... unique opportunity for venture capital funds, investment firms and animal health companies to ... Forum have raised $160 million. Several have also received licensing agreements or distribution ...
(Date:8/27/2015)... The National Necrotizing Fasciitis Foundation ... by doctors at Vanderbilt University Hospital in ... and Dr. John Crew , director of the ... Center in Daly City, CA. ... pioneered by Dr. Crew, that had previously saved the ...
Breaking Biology Technology:Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 2U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 3VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3
... Trial Meets Primary and Key Secondary Endpoints,NEW YORK, March ... results from the ITI-007 Phase II trial in patients ... ITI-007 significantly and dose-dependently increased slow wave sleep and ... measured by polysomnography (PSG), meeting the prespecified primary and ...
... Key Regulatory MilestoneLONDON, March 10 Monsanto,s historic ... biotechnology has contributed to a 24 percent compound annual ... since 2001. This is one of the key ... will tell investors today as part of a presentation ...
... been known for its world-record-breaking carbon nanotubes. Now ... new uses by spinning carbon nanotubes (CNTs) into ... Breakthroughs Without Broken Threads , Taking ... carbon nanotubes of world-record breaking lengths, researchers Vesselin ...
Cached Biology Technology:Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia 2Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia 3Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia 4Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia 5Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia 6Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia 7Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment 2Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment 3Spinning carbon nanotubes spawns new wireless applications 2
Purified anti-eIF-4E...
Peptide-affinity Purified Polyclonal Antibody to SMAD7 Peptide with sequence SSCPCWLEVIFNSR, from C Terminus of the protein sequence according to NP_005895....
Purified anti-PXR...
Polyclonal Antibody to PRG3...
Biology Products: